Form EFFECT Vaxart, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 18, 2026 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vaxart reports no serious adverse events in oral COVID vaccine trial
- Greenfire Resources Announces Acquisition of Connacher Oil and Gas Limited for C$1.277 Billion in Cash Consideration
- Cynosure Lutronic Brings Next-Generation Monopolar RF to Europe as Patient Demand for Non-Invasive Skin Tightening Reaches New Heights
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
